1. Home
  2. NSRX vs TACT Comparison

NSRX vs TACT Comparison

Compare NSRX & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.08

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$5.10

Market Cap

35.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSRX
TACT
Founded
2019
1996
Country
Israel
United States
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
35.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NSRX
TACT
Price
$3.08
$5.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$19.67
$5.00
AVG Volume (30 Days)
20.6K
63.8K
Earning Date
03-25-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.88
EPS
N/A
0.07
Revenue
N/A
N/A
Revenue This Year
N/A
$10.36
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$73.71
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$3.06
52 Week High
$9.99
$6.02

Technical Indicators

Market Signals
Indicator
NSRX
TACT
Relative Strength Index (RSI) 43.46 52.47
Support Level $2.78 $5.05
Resistance Level $3.58 $5.86
Average True Range (ATR) 0.22 0.39
MACD -0.05 -0.08
Stochastic Oscillator 0.00 30.52

Price Performance

Historical Comparison
NSRX
TACT

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: